LATEST
Cencora agreed to acquire American Oncology NetworknewAPEX / KorainewSmith & Wesson Brands agreed to acquire Long Range IntermediatenewBose acquired SkullcandyMaximus Federal Services agreed to acquire Agile DefenseMount Logan Management agreed to acquire Alternative Fund AdvisorsDime Commercial Bancshares / ES BancsharesSalesforce agreed to acquire BrazeJV Investors / Oro Mobility HoldingsMorgan Stanley Capital Partners acquired The Rapid GroupCBRE Group agreed to acquire Onnec GroupBevPoint Capital agreed to acquire ESG
Open App
Agreement signedPublished 27 Oct 2022

Sagard Healthcare Partners /
Agios Pharmaceuticals, Inc.

Sagard Healthcare Partners purchases Agios royalty rights for $131.8 million

Price
$131.8m
Stage
Agreement signed
Buy side: Sagard Healthcare Partners
Buy sideSagard Healthcare Partners
Target: Agios Pharmaceuticals, Inc.
TargetAgios Pharmaceuticals, Inc.
Source · 27 Oct 2022
See the source
Buy side: Sagard Healthcare Partners
Buy sideSagard Healthcare Partners
Target: Agios Pharmaceuticals, Inc.
TargetAgios Pharmaceuticals, Inc.
01 / BuyerSagard Healthcare Partners
02 / TargetAgios Pharmaceuticals, Inc.
01

What happened

Agios Pharmaceuticals, Inc. sold its rights to royalties on U.S. sales of TIBSOVO to Sagard Healthcare Partners for a one-time payment of $131.8 million. Agios retained potential future milestone and royalty rights related to vorasidenib.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Sagard Healthcare Partners purchases Agios royalty rights for $131.8 million

This document is the source for the companies, stage, figure and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.